VEGFA and non-small cell lung carcinoma: Unlike other cancer subtypes like non-small cell lung cancer (NSCLC), bladder, or renal cell cancer, combinatorial approaches of chemoimmunotherapy or adding VEGF inhibitors or local ablation to immunotherapy can result in improved outcomes for patients with CCA.